title: Lack of imatinib-induced thyroid dysfunction in a cohort of non-thyroidectomized patients.
authors.forename: José Miguel
authors.initials: JM
authors.lastname: Dora
authors.forename: Murilo Anderson
authors.initials: MA
authors.lastname: Leie
authors.forename: Bruno
authors.initials: B
authors.lastname: Netto
authors.forename: Laura Maria
authors.initials: LM
authors.lastname: Fogliatto
authors.forename: Lucia
authors.initials: L
authors.lastname: Silla
authors.forename: Felipe
authors.initials: F
authors.lastname: Torres
authors.forename: Ana Luiza
authors.initials: AL
authors.lastname: Maia
mesh_terms: D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001549:Benzamides; D015331:Cohort Studies; D005260:Female; D006801:Humans; D000068877:Imatinib Mesylate; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D010879:Piperazines / Q000008:administration & dosage / Q000009:adverse effects*; D011743:Pyrimidines / Q000008:administration & dosage / Q000009:adverse effects*; D013959:Thyroid Diseases / Q000139:chemically induced*; D013965:Thyroidectomy
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate